Search For "clinical trial"
Phase 3 trials of Russian COVID-19 vaccine to start in Philippines in Octo
Updated : 5 years, 7 months ago IST
Manila [Philippines], August 13 (ANI/Sputnik): Phase 3 clinical trials of the Russian COVID-19 vaccine will be held in the Philippines from October to March, Philippine presidential spokesperson Harry Roque said on Thursday.
Read More
At Rs 2,800, Zydus launches Remdac for treatment of COVID-19 in India
Updated : 5 years, 7 months ago IST
Ahmedabad (Gujarat) [India], Aug 13 (ANI): Pharmaceutical major Zydus Cadila said on Thursday it has launched Remdesivir under the brand name Remdac for treatment of COVID-19 in the Indian market.
Read More
Philippine President Duterte volunteers to be test subject for Russia-made
Updated : 5 years, 7 months ago IST
Manila [The Philippines], Aug 11 (ANI/Sputnik): Philippine President Rodrigo Duterte has said that he would volunteer to take the Russia-made coronavirus vaccine to test it, and the country's government on Tuesday voiced a readiness to cooperate with Moscow on the vaccine's clinical trials a
Read More
NIH launches clinical trial in US to test potential therapeutics for mild,
Updated : 5 years, 7 months ago IST
Washington D.C. [US], Aug 5 (Xinhua/ANI): The U.S. National Institutes of Health (NIH) said on Tuesday a Phase 2 clinical trial will evaluate the safety and efficacy of potential new therapeutics for COVID-19, including an investigational therapeutic based on synthetic monoclonal antibodies
Read More
DCGI gives nod to Serum Institute to hold Phase II, III COVID vaccine tria
Updated : 5 years, 7 months ago IST
New Delhi [India], Aug 3 (ANI): The Drugs Controller General of India (DCGI) gave approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India, said the Ministry of Health and Family Welfare on
Read More
No silver bullet for COVID-19 at present, there might never be: WHO
Updated : 5 years, 7 months ago IST
Geneva [Switzerland], Aug 3 (ANI): A number of coronavirus vaccines are now in phase three of clinical trials but "there's no silver bullet at the moment and there might never be," Tedros Adhanom Ghebreyesus, World Health Organisation Director-General said on Monday.
Read More
DCGI nod to Serum-Oxford COVID19 vaccine for phase 2, 3 clinical trials in
Updated : 5 years, 7 months ago IST
New Delhi, [India], Aug 3 (ANI) India's top drug regulator-- Drugs Controller General of India (DCGI) has granted permission to Serum Institute of India (SII) to conduct phase 2 and 3 human clinical trials in India on the potential COVID19 vaccine, a senior government official said.
Read More
Drug regulator gets committee approval for nod to clinical trials by Serum
Updated : 5 years, 7 months ago IST
New Delhi [India], July 31 (ANI): The Subject Expert Committee at Central Drugs Standard Control Organisation (CDSCO) has recommended to the top drug regulator to grant permission to Serum Institute of India (SII) to conduct phase two and three clinical trials in India on a potential COVID-1
Read More
COVID-19 vaccine development: Only 3 vaccine candidates in phase III acros
Updated : 5 years, 7 months ago IST
New Delhi [India], July 30 (ANI): In the development related to the COVID-19 vaccine across the world, only three vaccine candidates are in phase III clinical trials across the globe. These three coronavirus vaccine candidates are from the USA, UK (University of Oxford's vaccine) and Chin
Read More
Drug Regulator asks Serum Institute to furnish revised protocol for COVID-
Updated : 5 years, 7 months ago IST
New Delhi [India], July 29 (ANI): The Central Drugs Standard Control Organisation (CDSCO) has advised the Serum Institute of India (SII) to submit a revised protocol to perform the clinical trials in India for potential COVID-19 vaccine.
Read More
Domestic pharma giant SII applies to DCGI for phase 2/3 clinical trial of
Updated : 5 years, 7 months ago IST
New Delhi [India], July 25 (ANI): In a development related to the COVID-19 vaccine, the Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) for conducting the Phase 2/3 human clinical trials for a potential coronavirus vaccine.
Read More
COVID-19: AIIMS administers first dose of COVID-19 candidate vaccine `Cova
Updated : 5 years, 7 months ago IST
New Delhi [India], July 24 (ANI): The All India Institute of Medical Sciences (AIIMS) on Friday administered the first dose of country's first indigenous vaccine candidate `Covaxin' to a 30-year-old man as part of efforts to combat COVID-19.
Read More